Art
J-GLOBAL ID:201102220488874616   Reference number:11A0934864

難治性GERDの治療戦略 胃内pHからみたラベプラゾールナトリウムの1日2回投与の有用性-難治性GERDに対するオプションとして

Author (4):
Material:
Volume: 52  Issue:Page: 362-369  Publication year: Apr. 28, 2011 
JST Material Number: X0111A  ISSN: 1884-2895  Document type: Article
Article type: 解説  Country of issue: Japan (JPN)  Language: JAPANESE (JA)
Thesaurus term:
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
,...
Semi thesaurus term:
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
,...
   To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=11A0934864&from=J-GLOBAL&jstjournalNo=X0111A") }}
JST classification (1):
JST classification
Category name(code) classified by JST.
Drug therapy(=pharmacotherapy)for digestive system diseases 
Substance index (1):
Substance index
Chemical Substance indexed to the Article.
Reference (19):
  • 1) Cloud ML, Enas N, Humphries TJ, Bassion S. Rabeprazole in treatment of acid peptic diseases : results of three placebo-controlled dose-response clinical trials in duodenal ulcer, gastric ulcer, and gastroesophageal reflux disease (GERD) . Dig Dis Sci 1998 ; 43 : 993.
  • 2) Robinson M, Fitzgerald S, Hegedus R, et al. FAST Trial Investigators. Onset of symptom relief with rabeprazole : a community-based, open-label assessment of patients with erosive oesophagitis. [Erratum in : Aliment Pharmacol Ther 2002 ; 16 : 1035] . Aliment Pharmacol Ther 2002 ; 16 : 445.
  • 3) Miwa H, Sasaki M, Furuta T, et al. Efficacy of rabeprazole on heartburn symptom resolution in patients with non-erosive and erosive gastro-oesophageal reflux disease : a multicenter study from Japan. Aliment Pharmacol Ther 2007 ; 26 : 69.
  • 4) Sugimoto M, Furuta T, Shirai N, et al. Different dosage regimens of rabeprazole for nocturnal gastric acid inhibition in relation to cytochrome P450 2C19 genotype status. Clin Pharmacol Ther 2004 ; 76 : 290.
  • 5) Peghini PL, Katz P0, Casten DO. Ranitidine controls nocturnal gastric acid breakthrough on omeprazole : a controlled study in normal subjects. Gastroenterology 1998 ; 115 : 1335.
more...

Return to Previous Page